Disease Management: Breast Cancer  

V. Craig Jordan, PhD, D.Sc; Gabriel Hortobagyi, MD, FACP; Monica Morrow, MD

Long Term Tamoxifen Treatment for Breast Cancer, High Dose Combination Chemotherapy, and Issues in the Local Therapy of Breast Cancer.

Treatment of Metastatic Breast Cancer 

Aman U. Buzdar, MD; I. Craig Henderson, MD; Howard Hochster, MD

Discuss the diagnosis and treatment of breast cancer; Presentations on 1st and 2nd line treatments will cover cytotoxic chemotherapy (CMF, CAF, and new cytotoxic agents); Diverse hormonal agents, neoadjuvant treatments, and combination therapies.

Cancer Update: Breast Cancer

Gabriel Hortobagyi, MD; Barbara L. Weber, MD; Charles L. Vogel, MD

Intro on the Management of Advanced Breast Cancer and the Use of Standard Chemotherapy; Current Hormonal Therapy and New Hormonal Agents in the Management of Breast Cancer; New Agents, including Taxol and Taxotere; Use of Navelbine and Clinical Trial Results.

Stephen Colucciello, MD

Discuss the importance of trauma in pregnancy and emphasize the team approach; discuss frequency & types of trauma seen during pregnancy; know of physiological changes during pregnancy that affect the management of a trauma victim; discuss abruptio placenta; uterine rupture, amniotic fluid embolism; and penetrating uterine trauma; be aware of history and physical assessments in the field; discuss pre-hospital management, stabilization, transport issues; contact with the receiving hospital and special circumstances such as burns, electrical injuries and cardiac arrest.

Brenda L. Haile, RN, DrPH; Joseph C Gathe, Jr., MD, FACP; Patricia D. Salvato, MD

Introduce to women, nurses and healthcare workers the latest information on HIV & AIDS as it relates to women; Be able to elaborate on current developments in the treatment of HIV and AIDS focusing on women; update the community on HIV & AIDS knowledge gained at the 12th World AIDS Conference in Geneva, Switzerland.

Ann McCloud Sneath, RN, MSN,CRNP; Amy Levi, CNM, MSN; Monica Choi, PhD, CRNP

Identify various types of STDs in women by taking sexual histories; Educate adolescents on healthy behaviours; Recognize the types of STDs that require and/or treatment; Recognize that patients may have coexisting STD's; Identify resources for recommended treatments; Identify high risk behaviours through history and a physical; Counsel sexually active women in choosing contraceptives methods that will reduce their risks of STD's; Educate women on gender-related risk factors for acquiring STD's.

Laszlo Tabar, MD; Linda Warren, MD; Richard Bird, MD; Jeffery Weinreb, MD; Kevin Fox, MD; Barbara Fowble, MD; Michael Osborne, MD; John Hainsworth, MD

Topics included in this program are: The effectiveness of mammographic screening; the diagnostic workup: mammography, sonography, MRI; and therapeutic options: radiotherapy, chemotherapy, and surgury.

Anthony Lucci, MD; Russel L. Malinak, MD; Joseph R. Feste, MD; Geof Tidey, MD

These doctors address the following endometriosis issues: diagnosis and early management; classifications of treatment; operative treatment; and medical treatment and management.

John Sandbach, MD; Gillian Newstead, MD; Christopher Merritt, MD; Ellen Mendelson, MD; Jeff Weinreb, MD; Mitch Schnall, MD

Role of mammography in the diagnosis of breast cancer, breast ultrasound, role of MRI in evaluation of breast disease, ultrasound guided fine needle aspiration.

Wulf H. Utian, MD, PhD; Frank Bellino, PhD; Arie Birkenfeld, MD; Matan Yemini, MD; Mary Ellen Kennedy, RN

Comprehensive Health Care to the Peri-Menopause; Current Research Trends; Hormone Replacement Therapy; What is Menopause?; Nursing Perspectives in Menopause Management.

Harold Harvey, MD; Richard Santen, MD; Paul Goss, MD; Andrea Manni, MD

Topics covered in this program include: new aromatase inhibitors; risks and benefits of adjuvant tamoxifen; potential prevention of breast cancer by hormonal therapies; optimal duration therapy with tamoxifen; post-menopausal estrogen replacement therapy.

Martin Weisberg, MD; Vanessa E. Cullins, MD, MPH; James A. McGregor, MD, CM; Ron Burkman, MD; J. Kell Williams, MD; Geoffrey Redmond, MD

Diagnosing vulvovaginal candidiasis; shift of pathogens responsible; oral therapy; oral contraceptives; clinical features suggestive of androgen-related disorders; identify subgroups of women at risk; recognize modes of therapy.

Harold Harvey, MD; Richard Santen, MD; Paul Goss, MD; Andrea Manni, MD

Topics covered in this program include: new aromatase inhibitors; risks and benefits of adjuvant tamoxifen; potential prevention of breast cancer by hormonal therapies; optimal duration therapy with tamoxifen; post-menopausal estrogen replacement therapy.

David J. Baylink, MD; Robert Lindsay, MD; Michael J. Maricic, MD; Charles H. Chestnut, III, MD

Focuses on this prevalent disease, which is gaining increased attention as an important issue in woman's health and geriatric medicine. Program also focuses on the fundamentals of agents used for the treatment of osteoporosis, including side effects, efficacy, compliance, dosage regimen, and the need for additional drugs.

Steven F. Pariser, MD; Kimberly A. Yonkers, MD; Susan Kornstein, MD; Anthony Rothschild, MD; Lee Cohen, MD; Zachary N. Stowe, MD

Premenstrual Dysphoric Disorder; Treatment Options for the Female Patient; Menopause, Peri-Menopause, and Depression; Depression in Pregnancy and the Postpartum State.

I. Craig Henderson, MD; John Kennedy, MD, FRCPI; William Gradishar, MD; Claudine Isaacs, MD

Leading medical experts making presentations on advances in the management and treatment of breast cancer, including new agents and combination therapies, emphasizing the role of chemotherapy.